PRNewsWire - Health - Latest News Search Engine - Global and Local Breaking News

PRNewsWire - Health

Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints

Denifanstat (ASC40), a once-daily oral fatty acid synthase (FASN) inhibitor, demonstrated statistically significant and clinically meaningful improvem...

Ascletis Announces Phase III Trial of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne, Meets All Endpoints

BioVaxys Issues Corporate Update

VANCOUVER, BC, June 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a sum...

BioVaxys Issues Corporate Update

RxWellness Spine & Health Acquires AllCare Chiropractic & Injury, Expands Multi-Regional Footprint with Four New Maryland Clinics

HERNDON, Va., June 3, 2025 /PRNewswire/ -- RxWellness Spine & Health, the Mid-Atlantic's leading natural-first healthcare clinic network and platf...

RxWellness Spine & Health Acquires AllCare Chiropractic & Injury, Expands Multi-Regional Footprint with Four New Maryland Clinics

Sechstes globales Pharmaunternehmen wählt LifeSphere NavaX für GenAI-gesteuerte Fallbearbeitung

Unternehmen aus den weltweiten Top 25 der Life-Science-Branche führt NavaX ein und demonstriert damit das Vertrauen der Industrie in skalierbare, GenA...

Sechstes globales Pharmaunternehmen wählt LifeSphere NavaX für GenAI-gesteuerte Fallbearbeitung